Does RIBOFLAVIN 5'-PHOSPHATE Cause Therapy cessation? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Therapy cessation have been filed in association with RIBOFLAVIN 5'-PHOSPHATE. This represents 16.9% of all adverse event reports for RIBOFLAVIN 5'-PHOSPHATE.
42
Reports of Therapy cessation with RIBOFLAVIN 5'-PHOSPHATE
16.9%
of all RIBOFLAVIN 5'-PHOSPHATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy cessation From RIBOFLAVIN 5'-PHOSPHATE?
Of the 42 reports.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN 5'-PHOSPHATE. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOFLAVIN 5'-PHOSPHATE Cause?
Eye pain (60)
No adverse event (48)
Corneal opacity (38)
Corneal epithelium defect (29)
Visual impairment (25)
Photophobia (21)
Ocular discomfort (20)
Vision blurred (19)
Inappropriate schedule of drug administration (17)
Product use issue (17)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which RIBOFLAVIN 5'-PHOSPHATE Alternatives Have Lower Therapy cessation Risk?
RIBOFLAVIN 5'-PHOSPHATE vs RIBOFLAVIN 5^-PHOSPHATE
RIBOFLAVIN 5'-PHOSPHATE vs RIFABUTIN
RIBOFLAVIN 5'-PHOSPHATE vs RIFAMPICIN
RIBOFLAVIN 5'-PHOSPHATE vs RIFAMPIN
RIBOFLAVIN 5'-PHOSPHATE vs RIFAMYCIN